| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 1,363,636 | $11.00 | $14,999,996.00 | +4.5% | → |
| 2025-02-18 | Dickinson Andrew D | Chief Financial Officer | Sell | 2,500 | $104.09 | $260,225.00 | -1.5% | → |
| 2025-02-12 | Dickinson Andrew D | Chief Financial Officer | Sale+OE | 137,676 | $102.22 | $14,073,240.72 | -44.6% | → |
| 2025-01-31 | Dickinson Andrew D | Chief Financial Officer | Sale+OE | 142,180 | $97.22 | $13,822,739.60 | -52.3% | → |
| 2025-01-15 | Dickinson Andrew D | Chief Financial Officer | Sell | 2,500 | $91.35 | $228,375.00 | -1.9% | → |
| 2024-12-19 | GILEAD SCIENCES, INC. | - | Buy | 940,499 | $21.37 | $20,098,463.63 | +74.1% | → |
| 2024-12-18 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 1,759,978 | $1.04 | $1,830,377.12 | +24.0% | → |
| 2024-12-16 | Dickinson Andrew D | Chief Financial Officer | Sell | 8,500 | $91.96 | $781,660.00 | -6.0% | → |
| 2024-11-29 | Dickinson Andrew D | Chief Financial Officer | Sale+OE | 248,645 | $92.76 | $23,065,270.54 | -38.0% | → |
| 2024-11-27 | Parsey Merdad | Chief Medical Officer | Sale+OE | 164,211 | $91.92 | $15,094,013.40 | -22.9% | → |
| 2024-11-26 | Bluestone Jeffrey | Director | Sale+OE | 6,788 | $91.39 | $620,356.00 | -43.2% | → |
| 2024-11-06 | Mercier Johanna | Chief Commercial Officer | Sell | 5,000 | $91.28 | $456,400.00 | -6.4% | → |
| 2024-11-06 | Parsey Merdad | Chief Medical Officer | Sale+OE | 25,590 | $91.50 | $2,341,485.00 | -11.1% | → |
| 2024-10-01 | Parsey Merdad | Chief Medical Officer | Sell | 2,000 | $83.83 | $167,660.00 | -2.0% | → |
| 2024-09-12 | Parsey Merdad | Chief Medical Officer | Sale+OE | 21,246 | $84.50 | $1,795,287.00 | -17.2% | → |
| 2024-09-12 | Mercier Johanna | Chief Commercial Officer | Sell | 29,357 | $83.78 | $2,459,576.75 | -14.7% | → |
| 2024-08-28 | Mercier Johanna | Chief Commercial Officer | Sell | 9,513 | $78.03 | $742,299.39 | -8.3% | → |
| 2024-08-13 | Mercier Johanna | Chief Commercial Officer | Sell | 5,490 | $73.98 | $406,150.20 | -4.6% | → |
| 2024-07-01 | Parsey Merdad | Chief Medical Officer | Sell | 2,000 | $68.63 | $137,260.00 | -2.0% | → |
| 2024-06-17 | GILEAD SCIENCES, INC. | - | Buy | 179,500 | $0.00 | - | +16.5% | → |
| 2024-04-02 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 485,250 | $0.76 | $368,790.00 | +7.1% | → |
| 2024-04-01 | Parsey Merdad | Chief Medical Officer | Sell | 2,000 | $72.96 | $145,920.00 | -2.0% | → |
| 2024-02-29 | Parsey Merdad | Chief Medical Officer | Sell | 10,230 | $72.82 | $744,983.86 | -5.0% | → |
| 2024-02-12 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 910,000 | $22.00 | $20,020,000.00 | +28.3% | → |
| 2024-01-29 | GILEAD SCIENCES, INC. | - | Buy | 15,238,095 | $21.00 | $319,999,995.00 | +102.8% | → |
| 2024-01-16 | Dickinson Andrew D | Chief Financial Officer | Sell | 5,000 | $85.78 | $428,900.00 | -4.7% | → |
| 2024-01-09 | Mercier Johanna | Chief Commercial Officer | Sell | 8,242 | $85.23 | $702,465.66 | -9.1% | → |
| 2023-10-17 | Dickinson Andrew D | Chief Financial Officer | Sell | 5,000 | $80.00 | $400,017.00 | -4.6% | → |
| 2023-09-12 | Parsey Merdad | Chief Medical Officer | Sell | 1,501 | $76.99 | $115,561.99 | -2.1% | → |
| 2023-07-20 | Dickinson Andrew D | Chief Financial Officer | Sell | 5,000 | $80.00 | $400,000.00 | -4.4% | → |
| 2023-06-28 | GILEAD SCIENCES, INC. | - | Buy | 1,010,000 | $19.26 | $19,452,600.00 | +7.3% | → |
| 2023-06-27 | GILEAD SCIENCES, INC. | 10% Owner | Buy | 2,930,870 | $3.75 | $10,990,762.50 | +21.4% | → |
| 2023-06-13 | Parsey Merdad | Chief Medical Officer | Sell | 1,485 | $76.90 | $114,196.50 | -4.8% | → |
| 2023-03-13 | Parsey Merdad | Chief Medical Officer | Sell | 6,126 | $78.99 | $483,892.74 | -8.0% | → |
| 2023-03-01 | Parsey Merdad | Chief Medical Officer | Sell | 12,984 | $79.96 | $1,038,225.31 | -15.6% | → |
| 2022-12-30 | Parsey Merdad | Chief Medical Officer | Sell | 553 | $85.33 | $47,187.49 | -1.2% | → |
| 2022-11-09 | Wilfong Diane E. | SVP, Controller & CAO | Sale+OE | 6,416 | $83.50 | $535,736.00 | -18.5% | → |
| 2022-11-01 | Wilfong Diane E. | SVP, Controller & CAO | Sale+OE | 16,255 | $79.25 | $1,288,208.75 | -36.5% | → |
| 2022-03-11 | Pletcher Brett A | EVP,Corp Affairs & Gen Counsel | Sale+OE | 3,634 | $58.24 | $211,644.16 | -10.0% | → |
| 2022-02-09 | Pletcher Brett A | EVP,Corp Affairs & Gen Counsel | Sell | 1,691 | $63.89 | $108,037.99 | -4.9% | → |
| 2022-02-01 | Pletcher Brett A | EVP,Corp Affairs & Gen Counsel | Sell | 14,061 | $68.54 | $963,681.88 | -30.1% | → |
| 2021-08-17 | Wilfong Diane E. | SVP, Controller & CAO | Sale+OE | 13,610 | $72.50 | $986,725.00 | -40.0% | → |